Sunday, August 22, 2021 3:18:38 PM
OTCShotCaller. Thank you for all of your very informative posts. Thank all of you guys for all of the information you provide. I don't post much as I don't have a lot to offer. I just read a lot and follow and learn more everyday. The last part of this post confused me a little and I'm asking if I am missing something. You point out that Kite had 1 mrna patent and treatment in it's pipeline and sold for 12 billion. Regen has so much more going for it that's it's hard to compare the two. You have your projected buy out price for Regen at $1.25 per share which would be less than 5 billion total. Am I missing something? I know this is all speculation but isn't that kind of low?
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
